Tafenoquine succinate for malaria prevention.
出版信息
Aust Prescr. 2019 Jun;42(3):110-111. doi: 10.18773/austprescr.2019.034. Epub 2019 Apr 24.
Abstract
摘要
相似文献
1
Tafenoquine succinate for malaria prevention.
Aust Prescr. 2019 Jun;42(3):110-111. doi: 10.18773/austprescr.2019.034. Epub 2019 Apr 24.
2
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
Lancet. 2014 Mar 22;383(9922):1049-58. doi: 10.1016/S0140-6736(13)62568-4. Epub 2013 Dec 19.
3
Malaria chemoprophylaxis with tafenoquine: a randomised study.
Lancet. 2000 Jun 10;355(9220):2041-5. doi: 10.1016/S0140-6736(00)02352-7.
4
Tafenoquine for primary and terminal prophylaxis of malaria in apparently healthy people: a systematic review.
Trans R Soc Trop Med Hyg. 2019 Oct 11;113(10):579-586. doi: 10.1093/trstmh/trz052.
5
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
N Engl J Med. 2019 Jan 17;380(3):229-241. doi: 10.1056/NEJMoa1802537.
6
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects.
Antimicrob Agents Chemother. 2007 Aug;51(8):2709-15. doi: 10.1128/AAC.01183-06. Epub 2007 May 21.
7
Clinical utility of tafenoquine in the prevention of relapse of malaria: a review on the mode of action and emerging trial data.
Infect Drug Resist. 2019 Mar 6;12:553-570. doi: 10.2147/IDR.S151031. eCollection 2019.
8
Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Clin Infect Dis. 2004 Oct 15;39(8):1095-103. doi: 10.1086/424508. Epub 2004 Sep 24.
9
Tafenoquine: First Global Approval.
Drugs. 2018 Sep;78(14):1517-1523. doi: 10.1007/s40265-018-0979-2.
10
Tafenoquine for malaria prophylaxis in adults: An integrated safety analysis.
Travel Med Infect Dis. 2017 May-Jun;17:19-27. doi: 10.1016/j.tmaid.2017.05.008. Epub 2017 May 8.
本文引用的文献
1
Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects.
Antimicrob Agents Chemother. 2010 Feb;54(2):792-8. doi: 10.1128/AAC.00354-09. Epub 2009 Dec 7.
2
Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
J Infect Dis. 2004 Oct 15;190(8):1456-63. doi: 10.1086/424468. Epub 2004 Sep 20.
3
A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
Clin Infect Dis. 2003 Mar 1;36(5):541-9. doi: 10.1086/367542. Epub 2003 Feb 14.
4
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
Clin Infect Dis. 2001 Dec 15;33(12):1968-74. doi: 10.1086/324081. Epub 2001 Nov 7.
5
Malaria chemoprophylaxis with tafenoquine: a randomised study.
Lancet. 2000 Jun 10;355(9220):2041-5. doi: 10.1016/S0140-6736(00)02352-7.
Zotero 插件